These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11248905)

  • 21. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 22. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
    Oliveira AF; Silva GA; Almeida DM
    Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trismus as the first symptom of amyotrophic lateral sclerosis.
    Cisse FA; Dubois-Boissier MD; Jousserand G; Antoine JC; Camdessanche JP
    Amyotroph Lateral Scler; 2012 Sep; 13(5):475-6. PubMed ID: 22670882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialorrhoea and reversals in ALS functional rating scale.
    Pinto S; Gromicho M; de Carvalho M
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):187-188. PubMed ID: 27634984
    [No Abstract]   [Full Text] [Related]  

  • 25. Botulinum toxin B reduces sialorrhea in parkinsonism.
    Racette BA; Good L; Sagitto S; Perlmutter JS
    Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis.
    McGeachan AJ; Hobson EV; Al-Chalabi A; Stephenson J; Chandran S; Crawley F; Dick D; Donaghy C; Ellis CM; Gorrie G; Hanemann CO; Harrower T; Jung A; Malaspina A; Morrison KE; Orrell RW; Talbot K; Turner MR; Williams TL; Young CA; Shaw PJ; McDermott CJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):1-9. PubMed ID: 27579520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.
    Winterholler MG; Heckmann JG; Hecht M; Erbguth FJ
    Neurology; 2002 Feb; 58(3):502-3. PubMed ID: 11839868
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comments on 'The treatment of sialorrhea with botulinum toxin'].
    Arnold G; Kupsch ; Trottenberg T; Lipp A
    Nervenarzt; 2005 Oct; 76(10):1273. PubMed ID: 16468134
    [No Abstract]   [Full Text] [Related]  

  • 30. Manually guided botulinum toxin type A submandibular injections for the treatment of sialorrhea in tube-fed patients with advanced amyotrophic lateral sclerosis.
    Rodriguez-Murphy E; Marti-Bonmati E; Camps-Seguí E; Bagán JV
    Am J Health Syst Pharm; 2011 Sep; 68(18):1680-1. PubMed ID: 21880878
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
    Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
    Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands].
    Carod Artal FJ
    Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teaching Video NeuroImage: Disabling Jaw Clonus in a Patient With Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated With Botulinum Toxin.
    Oliveira Santos M; Schön M; Valadas A; de Carvalho M
    Neurology; 2022 Oct; 99(15):671. PubMed ID: 36216527
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin type B for sialorrhea in children with cerebral palsy.
    Reddihough D; Graham HK
    Dev Med Child Neurol; 2011 Jun; 53(6):488-9. PubMed ID: 21501158
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of sialorrhea in amyotrophic lateral sclerosis.
    Tysnes OB
    Acta Neurol Scand Suppl; 2008; 188():77-81. PubMed ID: 18439227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
    Hosp C; Naumann MK; Hamm H
    Semin Neurol; 2016 Feb; 36(1):20-8. PubMed ID: 26866492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.